Document ID: chunk:federal_register_of_legislation:F2022L00268:reg:8
Version: federal_register_of_legislation:F2022L00268
Segment Type: reg
Provision Reference: reg 8
Character Range: 4438–5425

8               Factors that must exist
At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting vaccine-induced thrombotic thrombocytopaenia or death from vaccine-induced thrombotic thrombocytopaenia with the circumstances of a person's relevant service:
(1)          having received an adenovirus vector coronavirus disease 2019 (COVID-19) vaccine within the 100 days before the clinical onset of vaccine-induced thrombotic thrombocytopaenia;
Note: Examples of adenovirus vector COVID-19 vaccines include:

               (a)             Ad26.COV2.S (Janssen COVID-19 Vaccine);
               (b)            ChAdOx1 nCoV-19 (Vaxevria, Oxford/Astra-Zeneca);
               (c)             Gam-COVID-Vac (Sputnik V, Sputnik Light); and
               (d)            AD5-nCOV (Convidecia).
(2)          inability to obtain appropriate clinical management for vaccine-induced thrombotic thrombocytopaenia.